SINGAPORE] United States-based biotechnology company Allay Therapeutics on Thursday (Jun 5) announced it has raised US$57.5 ...

Vertex Minerals Limited (ASX:VTX) announced the early closure of its Share Purchase Plan (SPP) on June 6, 2025, after ...

Vertex Pharmaceuticals has caught investors’ eyes, but its stock performance isn’t exactly a mic-drop moment. Despite massive ...

Short interest in Vertex Pharmaceuticals jumped 27.5% in May, hitting 4.82 million shares—just under 2% of the float. This ...

Stakeholders agree that the regulatory overhaul sends a strong signal to both local and international investors, positioning ...

Some investors are staying away from the market right now due to the volatility stocks have experienced this year and the ...

One stock that divides many investors at this time is Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG). Early on, the company built up ...

Trillion-dollar market valuations remain a rare milestone, typically only achieved through extraordinary corporate success ...

The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.

During its inaugural developer conference, Anthropic launched two new AI models the startup claims are among the industry's ...

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.